As per Global Insight services’ assessment, about 80+ prominent pharma and biotech giants are working on 80+ drugs in the Hypertension – pipeline landscape globally. Hypertension Pipeline Insight, 2023” report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies :https://www.globalinsightservices.com/request-sample/GIS31092
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side effects of drugs etc).
The most common causes of Hypertension include underlying diseases, side effects of medications, age, overweight, genetics, high sodium intake, alcohol consumption, stress, lifestyle, pregnancy.
Report Highlights
Global Insight Service’s, Hypertension – Drug Pipeline Landscape, 2023 report provides an overview of the Hypertension pipeline drugs. This report covers detailed insights on Anti-hypertension drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Anti-hypertension pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
- Aadi Bioscience, Inc.
- Addpharma Inc.
- Aeon Respire Inc
- Aerami Therapeutics
- Aerovate Therapeutics
- Ahn-Gook Pharmaceuticals Co.,Ltd
- AI Therapeutics
- AJU Pharm Co., Ltd.
- Alnylam Pharmaceuticals
- Altavant Sciences GmbH
- Annapurna Bio Pty Ltd
- Antlia Bioscience Inc
Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS31092
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like –
– Late-stage products (Phase III)
– Mid-stage products (Phase II)
– Early-stage product (Phase I)
– Pre-clinical and Discovery stage candidates
– Discontinued & Inactive candidates
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/